Neurostimulation for Post-Stroke Aphasia

Neurostimulation for the Treatment of Post-Stroke Aphasia

Recruiting N/A Interventional Study
Post-stroke Aphasia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
64 (estimated)
Sponsor
QVITI S.A. · Industry
Who this trial is looking for

This trial is looking for people who have difficulty speaking after a stroke. Participants will receive a type of brain stimulation while doing language tasks to see if it helps improve their speaking ability.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with aphasia.
  • I can do a naming task with 10-60% accuracy.
  • I had my first stroke more than 6 months ago.
  • I am between 18 and 80 years old.
  • I am right-handed.
  • I can give informed written consent.
  • I am fluent in English.

You may not be able to join if

  • I have severe cognitive problems that affect my ability to understand or follow commands.
  • I have metal implants in my skull.
  • I have untreated or unstable psychiatric illness.
  • I have a history of epilepsy or seizures.
  • I take medication that increases the risk of seizures.
  • I have a cardiac device like a pacemaker.
  • I had speech or hearing disabilities during childhood.
  • I am pregnant.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The aim of the trial is to determine whether 75Hz transcranial alternating current stimulation (tACS) synchronized with therapeutic linguistic tasks is an effective form of therapy for post-stroke aphasia.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Individuals with aphasia (assessed using the Boston Diagnostic Aphasia Examination) who perform the Naming Task in the range of 10%-60% accuracy will be included in the study. The overall baseline score in the Naming Task will be estimated from the two baseline measurements. Inclusion Criteria: * …
Contacts

Tertia Jeppson

312-238-6163

tjeppson@sralab.org

CONTACT

Aidan Rogers

(718) 308-9450

aidan.rogers@mountsinai.org

CONTACT